Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWise Group Regulatory News (WISE)

Share Price Information for Wise Group (WISE)

Share Price is delayed by 15 minutes
Get Live Data
838.80    14.80 (1.80%)
Bid:
836.00
Ask:
840.80
Spread: 4.80 (0.574%)
Market Cap: £8.39b
WISE Live PriceLast checked at - London Stock Exchange

Intraday Wise Group Share Chart

Half-year Report

29 Nov 2021 14:38

RNS Number : 9227T
Wise PLC
29 November 2021
 

Wise plc

29 November 2021

 

Release of unaudited historic financial information

 

Wise is today releasing selected historic consolidated financial statements on an unaudited half yearly basis for the year ended 31 March 2021.

 

 

Enquiries

Martin Adams - Head of Owner Relations

martin.adams@wise.com

 

 

Condensed consolidated statement of comprehensive income (unaudited)

 

 

Year ended

Half-year ended

Half-year ended

£m (unless otherwise noted)

31 March 2021

30 September 2020

31 March 2021

Revenue

421.0

192.2

228.8

Cost of sales

(151.7)

(71.8)

(79.9)

Net credit losses on financial assets

(8.8)

(1.2)

(7.6)

Gross profit

260.5

119.2

141.3

Administrative expenses

(217.5)

(97.6)

(119.9)

Interest income from investments and operating assets

1.9

1.0

0.9

Interest expense from operating assets

(3.8)

(1.6)

(2.2)

Other income

3.8

1.1

2.7

Operating profit

44.9

22.1

22.8

Finance expense

(3.8)

(2.1)

(1.7)

Profit before tax

41.1

20.0

21.1

Income tax expense

(10.2)

(5.4)

(4.8)

Profit for the period

30.9

14.6

16.3

Other comprehensive income

Items that may be reclassified to profit or loss:

Fair value (loss)/gain on investments

(3.0)

0.2

(3.2)

Currency translation differences

(3.8)

0.3

(4.1)

Total other comprehensive (loss)/income

(6.8)

0.5

(7.3)

Total comprehensive income for the period

24.1

15.1

9.0

 

 

 

Condensed consolidated statement of financial position (unaudited)

 

 

As at 31 March

As at 30 September

As at 31 March

£m

2020

2020

2021

Non-current assets

Deferred tax assets

32.0

38.7

56.7

Property, plant and equipment

19.1

16.7

24.0

Intangible assets

21.3

24.4

27.5

Trade and other receivables

7.6

8.3

15.1

Total non-current assets

80.0

88.1

123.3

Current assets

Current tax assets

2.1

1.7

1.1

Trade and other receivables

102.6

89.2

81.3

Short-term financial investments

114.1

289.3

737.5

Cash and cash equivalents

2,077.6

2,872.1

3,358.6

Total current assets

2,296.4

3,252.3

4,178.5

Total assets

2,376.4

3,340.4

4,301.8

Non-current liabilities

Deferred tax liabilities

-

-

2.0

Non-current borrowings

59.6

9.0

95.2

Non-current trade and other payables

7.4

9.5

22.6

Total non-current liabilities

67.0

18.5

119.8

Current liabilities

Borrowings

4.2

28.3

3.5

Current tax liabilities

0.7

0.8

2.0

Trade and other payables

2,107.7

3,051.2

3,891.2

Total current liabilities

2,112.6

3,080.3

3,896.7

Total liabilities

2,179.6

3,098.8

4,016.5

Equity

Share capital

9.4

9.4

9.4

Equity merger reserve

111.1

112.0

(8.0)

Share-based payment reserves

63.8

90.0

124.5

Own shares reserve

-

-

-

Other reserves

2.3

2.5

(0.7)

Retained earnings

8.9

26.1

162.6

Currency translation differences

1.3

1.6

(2.5)

Total equity

196.8

241.6

285.3

Total liabilities and equity

2,376.4

3,340.4

4,301.8

 

 

Condensed consolidated statement of cash flows (unaudited)

 

 

 

£m

Year ended

Half-year ended

Half-year ended

31 March 2021

30 September 2020

31 March 2021

Cash flows from operating activities

Cash generated from operations

2,076.3

1,012.0

1,064.3

Interest received

7.6

2.7

4.9

Interest expense paid

(6.0)

(2.7)

(3.3)

Corporate income tax paid

(4.0)

(0.8)

(3.2)

Net cash generated from operating activities

2,073.9

1,011.2

1,062.7

Cash flows from investing activities

Payments for property, plant and equipment

(2.3)

(1.1)

(1.2)

Payment for intangible assets

(20.9)

(10.1)

(10.8)

Payments for financial assets at FVOCI

(723.9)

(222.7)

(501.2)

Proceeds from sale and maturity of financial assets at FVOCI

75.3

41.1

34.2

Net cash used in investing activities

(671.8)

(192.8)

(479.0)

Cash flows from financing activities

Proceeds from issues of shares and other equity

0.9

0.9

-

Proceeds from borrowings

118.6

25.0

93.6

Repayments of borrowings

(90.0)

(50.0)

(40.0)

Payments for lease liabilities

(4.7)

(2.4)

(2.3)

Net cash generated from financing activities

24.8

(26.5)

51.3

Net increase in cash and cash equivalents

1,426.9

791.9

635.0

Cash and cash equivalents at beginning of the period

2,077.6

2,077.6

2,872.1

Effects of exchange rate changes on cash and cash equivalents

(145.9)

2.6

(148.5)

Cash and cash equivalents at end of the period

3,358.6

2,872.1

3,358.6

 

 

Condensed consolidated statement of changes in equity (unaudited)

 

 

£m

Share capital

Equity merger reserve

Share-based payment reserves

Own shares reserve

Other reserves

Retained earnings

Currency translation differences

Total equity

At 1 April 2020

9.4

111.1

63.8

-

2.3

8.9

1.3

196.8

Profit for the period

-

-

-

-

-

14.6

-

14.6

Fair value gain on investments

-

-

-

-

0.2

-

-

0.2

Foreign currency translation differences

-

-

-

-

-

-

0.3

0.3

Total comprehensive income for the period

-

-

-

-

0.2

14.6

0.3

15.1

Share-based employee compensation expense

-

-

18.0

-

-

-

-

18.0

Deferred tax on share-based compensation

-

-

10.8

-

-

-

-

10.8

Share options exercises

-

0.9

(2.6)

-

-

2.6

-

0.9

At 30 September 2020

9.4

112.0

90.0

-

2.5

26.1

1.6

241.6

Profit for the period

-

-

-

-

-

16.3

-

16.3

Fair value loss on investments

-

-

-

-

(3.2)

-

-

(3.2)

Foreign currency translation differences

-

-

-

-

-

-

(4.1)

(4.1)

Total comprehensive income for the period

-

-

-

-

(3.2)

16.3

(4.1)

9.0

Reduction of share capital

-

(120.0)

-

-

-

120.0

-

-

Share-based employee compensation expense

-

-

18.9

-

-

-

-

18.9

Deferred tax on share-based compensation

-

-

15.8

-

-

-

-

15.8

Share options exercises

-

-

(0.2)

-

-

0.2

-

-

At 31 March 2021

9.4

(8.0)

124.5

-

(0.7)

162.6

(2.5)

285.3

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR FLFVSLSLAFIL
Date   Source Headline
19th Jul 20237:00 amRNSDirector/PDMR Shareholding
18th Jul 20231:59 pmRNSDirector/PDMR Shareholding
18th Jul 20237:00 amRNSWise Plc Q1FY24 Trading Update
4th Jul 20233:22 pmRNSAnnual Financial Report
3rd Jul 20237:00 amRNSTotal Voting Rights
28th Jun 20234:00 pmRNSDirector/PDMR Shareholding
27th Jun 20237:00 amRNSWise plc Preliminary Results FY end 31 March 2023
15th Jun 20237:00 amRNSDirector/PDMR Shareholding
2nd Jun 20239:47 amRNSTotal Voting Rights
22nd May 20237:00 amRNSManagement Update
15th May 202312:31 pmRNSDirector/PDMR Shareholding
10th May 20239:30 amRNSManagement update
2nd May 20233:24 pmRNSDirector/PDMR Shareholding
2nd May 20237:00 amRNSTotal Voting Rights
25th Apr 20237:00 amRNSDirector/PDMR Shareholding
20th Apr 20237:00 amRNSDirector/PDMR Shareholding
19th Apr 20237:00 amRNSBoard Appointments
18th Apr 20237:00 amRNSWise Plc Q4 FY23 Trading Update
3rd Apr 202311:26 amRNSDirector/PDMR Shareholding
31st Mar 202312:47 pmRNSTotal Voting Rights
21st Mar 202311:24 amRNSTotal Voting Rights (Replacement)
21st Mar 202311:11 amRNSTotal Voting Rights (Replacement)
21st Mar 202310:40 amRNSTotal Voting Rights (Replacement)
24th Feb 20239:55 amRNSHolding(s) in Company
24th Feb 20237:00 amRNSHolding(s) in Company
23rd Feb 20232:43 pmRNSTotal Voting Rights
10th Feb 20232:22 pmRNSDirector/PDMR Shareholding
9th Feb 20237:00 amRNSAdditional Listing
6th Feb 202310:53 amRNSDirector/PDMR Shareholding
1st Feb 202311:13 amRNSTotal Voting Rights
18th Jan 20234:17 pmRNSDirector/PDMR Shareholding
17th Jan 20237:00 amRNSWise Plc Q3 FY23 Trading Update
3rd Jan 20237:00 amRNSTotal Voting Rights
20th Dec 20224:08 pmRNSGrant of Awards to CFO
8th Dec 20225:45 pmRNSHolding(s) in Company
5th Dec 202210:09 amRNSHolding(s) in Company
2nd Dec 20229:48 amRNSDirector/PDMR Shareholding
30th Nov 202212:10 pmRNSTotal Voting Rights
29th Nov 20227:00 amRNSWise Plc HY FY23 Interim Results
4th Nov 20222:16 pmRNSDirector/PDMR Shareholding
31st Oct 202210:31 amRNSTotal Voting Rights
21st Oct 202210:19 amRNSDirector/PDMR Shareholding
18th Oct 20227:00 amRNSStrong momentum in Q2, supports outlook for year
5th Oct 202212:06 pmRNSAdditional Listing
5th Oct 20229:00 amRNSAdditional Listing
29th Sep 20222:30 pmRNSGrowth momentum continues; guidance upgraded
23rd Sep 202212:29 pmRNSNotice of Results
22nd Sep 202210:29 amRNSHolding(s) in Company
22nd Sep 202210:18 amRNSAllotment of OwnWise Shares
13th Sep 202210:21 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.